Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001144204-19-035224
Filing Date
2019-07-19
Accepted
2019-07-19 17:01:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tv525494_424b5.htm 424B5 210695
2 GRAPHIC tv525494_img01.jpg GRAPHIC 16853
  Complete submission text file 0001144204-19-035224.txt   235151
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-222046 | Film No.: 19964026
SIC: 2836 Biological Products, (No Diagnostic Substances)